Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency

Federico Villa, Michaela Tutone, Gianluca Altamura, Sara Antignani, Agnese Cangini, Ida Fortino, Mario Melazzini, Francesco Trotta, Giovanni Tafuri and Claudio Jommi

Health Policy, 2019, vol. 123, issue 6, 595-600

Abstract: The aim of this paper is to investigate the determinants of the difference between the price proposal submitted by the industry and the final negotiated price. We used Italy as a case-study.

Keywords: Market access; Value-based pricing; AIFA; Italy; Managed entry agreements; Delta price; Drug price negotiation; Health technology assessment (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S016885101930079X
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:123:y:2019:i:6:p:595-600

DOI: 10.1016/j.healthpol.2019.03.009

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().